Development of meningitis during therapy with cefamandole.
D000667:Ampicillin / Q000627:therapeutic use; D002435:Cefamandole / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008583:Meningitis, Haemophilus / Q000139:chemically induced*
D002511:Cephalosporins; D002435:Cefamandole; D000667:Ampicillin